![[Breaking] Celltrion Announces Phase 3 Clinical Trial Results of 'Rekkirona'... "Efficacy and Safety Proven"](https://cphoto.asiae.co.kr/listimglink/1/2020120210173242872_1606871853.jpg)
[Asia Economy Reporter Chunhee Lee] Celltrion announced on the 14th that it has proven the efficacy and safety of its COVID-19 antibody treatment 'Rekkirona' by releasing the topline results of the global Phase 3 clinical trial.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
